Mudra Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 5 Year, 11 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.79 Cr
About Mudra Pharmachem
Mudra Pharmachem Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 February 2020 (Five years 11 days old ). Its registered office is in Gandhi Nagar, Gujarat, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹3.79 Cr.
Dinesh Amrutiya, Bhargav Patel, Rasila Amrutiya, and One other member serve as directors at the Company.
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239GJ2020PTC112733
- Company No.
112733
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Feb 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Mudra Pharmachem?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhargav Patel  | Director | 14-Feb-2020 | Current |
| Dinesh Amrutiya | Director | 14-Feb-2020 | Current |
| Rasila Amrutiya | Director | 14-Feb-2020 | Current |
| Arvindkumar Patel | Director | 04-Apr-2022 | Current |
Financial Performance of Mudra Pharmachem.
Enhance accessibility to Mudra Pharmachem's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Mudra Pharmachem?
Unlock access to Mudra Pharmachem's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹37.90 M
₹0
Charges Breakdown by Lending Institutions
- The Kalupur Commercial Co-Operative Bank Limited : 3.79 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Oct 2021 | The Kalupur Commercial Co-Operative Bank Limited | ₹3.79 Cr | Open |
How Many Employees Work at Mudra Pharmachem?
Unlock and access historical data on people associated with Mudra Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mudra Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mudra Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
